Total Payments
$2.7M
2024 Payments
$264,889
Companies
49
Transactions
4,183
Medicare Patients
6,604
Medicare Billing
$4.8M
Payment Breakdown by Category
Other$1.9M (68.5%)
Consulting$419,673 (15.3%)
Travel$363,429 (13.3%)
Food & Beverage$76,166 (2.8%)
Research$2,300 (0.1%)
Education$400.26 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.8M | 713 | 66.6% |
| Consulting Fee | $419,673 | 145 | 15.3% |
| Travel and Lodging | $363,429 | 1,083 | 13.3% |
| Food and Beverage | $76,166 | 2,202 | 2.8% |
| Honoraria | $41,901 | 18 | 1.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $10,585 | 1 | 0.4% |
| Unspecified | $2,300 | 1 | 0.1% |
| Education | $400.26 | 20 | 0.0% |
Payments by Type
General
$2.7M
4,182 transactions
Research
$2,300
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $730,971 | 964 | $0 (2024) |
| Lilly USA, LLC | $429,030 | 610 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $323,425 | 289 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $301,189 | 402 | $0 (2024) |
| Janssen Biotech, Inc. | $226,339 | 340 | $0 (2024) |
| PFIZER INC. | $193,217 | 345 | $0 (2024) |
| UCB, Inc. | $145,338 | 267 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $102,172 | 132 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $69,940 | 110 | $0 (2019) |
| Horizon Pharma plc | $40,467 | 71 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $264,889 | 422 | Janssen Biotech, Inc. ($105,786) |
| 2023 | $321,177 | 461 | AbbVie Inc. ($84,783) |
| 2022 | $316,404 | 484 | ABBVIE INC. ($100,235) |
| 2021 | $235,252 | 334 | AbbVie Inc. ($80,743) |
| 2020 | $248,401 | 338 | AbbVie Inc. ($101,283) |
| 2019 | $517,720 | 774 | AbbVie, Inc. ($164,183) |
| 2018 | $477,262 | 730 | Lilly USA, LLC ($102,134) |
| 2017 | $353,589 | 640 | AbbVie, Inc. ($82,875) |
All Payment Transactions
4,183 individual payment records from CMS Open Payments — Page 1 of 168
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/17/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $3,262.50 | General |
| Category: Immunology | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $147.37 | General |
| Category: Rheumatology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $16.21 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $67.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $35.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $12.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,900.00 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| 4-Year Results from the RAPID-PsA Phase 3 Randomized Placebo-Controlled Trial of Certolizumab Pegol in Psoriatic Arthritis | UCB, Inc. | $2,300 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,295 | 90,014 | $1.9M | $1.1M |
| 2022 | 21 | 1,258 | 50,867 | $1.9M | $980,883 |
| 2021 | 35 | 1,950 | 87,089 | $2.5M | $1.3M |
| 2020 | 33 | 2,101 | 105,627 | $2.6M | $1.5M |
Total Patients
6,604
Total Services
333,597
Medicare Billing
$4.8M
Procedure Codes
117
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 35 | 29,800 | $715,200 | $311,809 | 43.6% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 12 | 8,525 | $426,250 | $287,579 | 67.5% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 11 | 41,680 | $254,880 | $194,392 | 76.3% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 14 | 4,170 | $187,650 | $109,945 | 58.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 167 | 546 | $81,900 | $44,819 | 54.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 93 | 373 | $78,330 | $32,423 | 41.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,680 | $50,400 | $30,585 | 60.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 215 | $25,800 | $12,506 | 48.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 91 | 163 | $27,830 | $8,761 | 31.5% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 44 | 1,400 | $8,530 | $5,306 | 62.2% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 32 | 297 | $5,643 | $5,105 | 90.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 39 | 78 | $16,380 | $3,473 | 21.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 18 | 106 | $5,300 | $2,094 | 39.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 91 | 245 | $2,776 | $1,383 | 49.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 32 | 32 | $4,320 | $1,071 | 24.8% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 30 | 150 | $3,225 | $900.60 | 27.9% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 30 | 62 | $806.00 | $687.80 | 85.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 70 | 72 | $1,080 | $547.92 | 50.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 46 | $1,150 | $443.76 | 38.6% |
| 86225 | Measurement of dna antibody, native or double stranded | Office | 2023 | 32 | 33 | $495.00 | $435.94 | 88.1% |
| 86200 | Measurement of antibody for rheumatoid arthritis assessment | Office | 2023 | 30 | 31 | $434.00 | $385.60 | 88.8% |
| 86226 | Measurement of dna antibody, single stranded | Office | 2023 | 32 | 33 | $462.00 | $384.74 | 83.3% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 12 | 14 | $1,330 | $348.48 | 26.2% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 28 | 45 | $360.00 | $187.98 | 52.2% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 67 | 69 | $1,725 | $182.85 | 10.6% |
About Dr. Anthony Turkiewicz, MD
Dr. Anthony Turkiewicz, MD is a Rheumatology healthcare provider based in Mountain Brk, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558384024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Turkiewicz, MD has received a total of $2.7M in payments from pharmaceutical and medical device companies, with $264,889 received in 2024. These payments were reported across 4,183 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.8M).
As a Medicare-enrolled provider, Turkiewicz has provided services to 6,604 Medicare beneficiaries, totaling 333,597 services with total Medicare billing of $4.8M. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Mountain Brk, AL
- Active Since 07/25/2006
- Last Updated 08/29/2023
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1558384024
Products in Payments
- TALTZ (Drug) $314,540
- COSENTYX (Biological) $283,697
- RINVOQ (Biological) $235,602
- TREMFYA (Drug) $213,745
- XELJANZ (Drug) $193,037
- SIMPONI ARIA (Biological) $177,869
- STELARA (Biological) $141,735
- Humira (Biological) $136,016
- Cimzia (Drug) $102,372
- RINVOQ (Drug) $94,002
- SAPHNELO (Biological) $89,016
- SKYRIZI (Biological) $86,455
- Rinvoq (Biological) $77,885
- KEVZARA (Biological) $57,495
- KEVZARA SARILUMAB INJECTION (Biological) $46,309
- KRYSTEXXA (Drug) $40,150
- OLUMIANT (Drug) $35,237
- Actemra (Biological) $29,393
- TAVNEOS (Drug) $24,014
- DUZALLO (Drug) $13,353
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Mountain Brk
Dr. Peter Saway, Md, MD
Rheumatology — Payments: $297,472
Rheumatology $297,472
Dr. Joel Abbott, Md, MD
Rheumatology — Payments: $19,889
Rheumatology $19,889
Maura Kennedy, Md, MD
Rheumatology — Payments: $19,818
Rheumatology $19,818
Dr. William Paul, Md, MD
Rheumatology — Payments: $14,361
Rheumatology $14,361